(aka Journal of Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases -- MEEGID)

Infectious diseases constitute one of the main challenges to medical science in the coming century. The impressive development of molecular megatechnologies and of bioinformatics have greatly increased our knowledge of the evolution, transmission and pathogenicity of infectious diseases. Research has shown that host susceptibility to many infectious diseases has a genetic basis. Furthermore, much is now known on the molecular epidemiology, evolution and virulence of pathogenic agents, as well as their resistance to drugs, vaccines, and antibiotics. Equally, research on the genetics of disease vectors has greatly improved our understanding of their systematics, has increased our capacity to identify target populations for control or intervention, and has provided detailed information on the mechanisms of insecticide resistance.

However, the genetics and evolutionary biology of hosts, pathogens and vectors have tended to develop as three separate fields of research. This artificial compartmentalisation is of concern due to our growing appreciation of the strong co-evolutionary interactions among hosts, pathogens and vectors.

Infection, Genetics and Evolution and its companion congress [MEEGID](http://www.meegidconference.com/) (for Molecular Epidemiology and Evolutionary Genetics of Infectious Diseases) are the main forum acting for the cross-fertilization between evolutionary science and biomedical research on infectious diseases.

Infection, Genetics and Evolution is the only journal that welcomes articles dealing with the genetics and evolutionary biology of hosts, pathogens and vectors, and coevolution processes among them in relation to infection and disease manifestation. All infectious models enter the scope of the journal, including pathogens of humans, animals and plants, either parasites, fungi, bacteria, viruses or prions. The journal welcomes articles dealing with genetics, population genetics, genomics, postgenomics, gene expression, evolutionary biology, population dynamics, mathematical modeling and bioinformatics. We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .

（又名《传染病分子流行病学和进化遗传学杂志》——MEEGID）

传染病是未来世纪医学科学面临的主要挑战之一。分子巨型技术和生物信息学的迅猛发展极大地提高了我们对传染病进化、传播和致病性的认识。研究表明，宿主对许多传染病的易感性具有遗传基础。此外，现在人们对病原体的分子流行病学、进化和毒力以及它们对药物、疫苗和抗生素的耐药性有了更多的了解。同样，对疾病媒介遗传学的研究也极大地提高了我们对它们系统学的理解，提高了我们确定控制或干预目标人群的能力，并提供了有关杀虫剂耐药性机制的详细信息。

然而，宿主、病原体和媒介的遗传学和进化生物学往往发展为三个独立的研究领域。由于我们越来越认识到宿主、病原体和媒介之间强大的共同进化相互作用，这种人为的划分令人担忧。

《感染、遗传学和进化》及其配套会议 [MEEGID](http://www.meegidconference.com/)（传染病分子流行病学和进化遗传学）是进化科学与传染病生物医学研究相互交流的主要论坛。

《感染、遗传学和进化》是唯一一本欢迎发表有关宿主、病原体和媒介遗传学和进化生物学以及它们之间与感染和疾病表现有关的共同进化过程的文章的期刊。所有感染模型都属于该期刊的范围，包括人类、动物和植物的病原体、寄生虫、真菌、细菌、病毒或朊病毒。本期刊欢迎发表与遗传学、群体遗传学、基因组学、后基因组学、基因表达、进化生物学、种群动态、数学建模和生物信息学相关的文章。我们还为作者提供许多福利，例如免费 PDF、宽松的版权政策、爱思唯尔出版物的特别折扣等等。请点击此处了解有关我们作者服务的更多信息。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映传染病学-医学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为2.6，平均审稿速度为 约1月 约10.1周，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。